Open Collections

UBC Faculty Research and Publications

Review & Update 1998 Therapeutics Initiative (University of British Columbia)

Description

Therapeutics Letter 27 summarizes the findings of six randomized controlled trials (RCTs) and synthesizes the evidence from these trials in the context of previous letters relating to treatment of hypertension (Letters 7, 8, 9, 16), Type 2 diabetes (Letter 23), Lipid lowering therapy (Letter 24), and olanzapine (Letter 20).

Item Metadata

Title
Review & Update 1998
Alternate Title
Therapeutics Letter 27
Creator
Therapeutics Initiative (University of British Columbia)
Date Issued
1998-12
Description
Therapeutics Letter 27 summarizes the findings of six randomized controlled trials (RCTs) and synthesizes the evidence from these trials in the context of previous letters relating to treatment of hypertension (Letters 7, 8, 9, 16), Type 2 diabetes (Letter 23), Lipid lowering therapy (Letter 24), and olanzapine (Letter 20).
Subject
Antihypertensive Agents; Cholesterol; Diabetes Mellitus, Type 2; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Metformin; Olanzapine; Thiazides
Genre
Other
Type
Text
Language
eng
Notes
The UBC TI is funded by the BC Ministry of Health to provide evidence-based information about drug therapy. We neither formulate nor adjudicate provincial drug policies.
Date Available
2023-06-20
Provider
Vancouver : University of British Columbia Library
Rights
Attribution-NonCommercial-NoDerivatives 4.0 International
DOI
10.14288/1.0433606
URI
http://hdl.handle.net/2429/85016
Affiliation
Medicine, Faculty of; Anesthesiology, Pharmacology and Therapeutics, Department of
Peer Review Status
Reviewed
Scholarly Level
Faculty; Researcher
Rights URI
http://creativecommons.org/licenses/by-nc-nd/4.0/
Aggregated Source Repository
DSpace

Item Media

Item Citations and Data

Rights

Attribution-NonCommercial-NoDerivatives 4.0 International